Cargando…
De novo missense variant in GRIA2 in a patient with global developmental delay, autism spectrum disorder, and epileptic encephalopathy
De novo variants are increasingly recognized as a common cause of early infantile epileptic encephalopathies. We present a 4-yr-old male with epileptic encephalopathy characterized by seizures, autism spectrum disorder, and global developmental delay. Whole-genome sequencing of the proband and his u...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9235849/ https://www.ncbi.nlm.nih.gov/pubmed/35534222 http://dx.doi.org/10.1101/mcs.a006172 |
_version_ | 1784736407666819072 |
---|---|
author | Latsko, Maeson S. Koboldt, Daniel C. Franklin, Samuel J. Hickey, Scott E. Williamson, Rachel K. Garner, Shannon Ostendorf, Adam P. Lee, Kristy White, Peter Wilson, Richard K. |
author_facet | Latsko, Maeson S. Koboldt, Daniel C. Franklin, Samuel J. Hickey, Scott E. Williamson, Rachel K. Garner, Shannon Ostendorf, Adam P. Lee, Kristy White, Peter Wilson, Richard K. |
author_sort | Latsko, Maeson S. |
collection | PubMed |
description | De novo variants are increasingly recognized as a common cause of early infantile epileptic encephalopathies. We present a 4-yr-old male with epileptic encephalopathy characterized by seizures, autism spectrum disorder, and global developmental delay. Whole-genome sequencing of the proband and his unaffected parents revealed a novel de novo missense variant in GRIA2 (c.1589A > T; p.Lys530Met; ENST00000264426.14). Variants in the GRIA2 gene were recently reported to cause an autosomal dominant neurodevelopmental disorder with language impairments and behavioral abnormalities (OMIM; MIM #618917), a condition characterized by intellectual disability and developmental delay in which seizures are a common feature. The de novo variant identified in our patient maps to the edge of a key ligand binding domain of the AMPA receptor and has not been previously reported in gnomAD or other public databases, making it novel. Our findings provided a long-sought diagnosis for this patient and support the link between GRIA2 and a dominant neurodevelopmental disorder. |
format | Online Article Text |
id | pubmed-9235849 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Cold Spring Harbor Laboratory Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-92358492022-07-08 De novo missense variant in GRIA2 in a patient with global developmental delay, autism spectrum disorder, and epileptic encephalopathy Latsko, Maeson S. Koboldt, Daniel C. Franklin, Samuel J. Hickey, Scott E. Williamson, Rachel K. Garner, Shannon Ostendorf, Adam P. Lee, Kristy White, Peter Wilson, Richard K. Cold Spring Harb Mol Case Stud Rapid Communication De novo variants are increasingly recognized as a common cause of early infantile epileptic encephalopathies. We present a 4-yr-old male with epileptic encephalopathy characterized by seizures, autism spectrum disorder, and global developmental delay. Whole-genome sequencing of the proband and his unaffected parents revealed a novel de novo missense variant in GRIA2 (c.1589A > T; p.Lys530Met; ENST00000264426.14). Variants in the GRIA2 gene were recently reported to cause an autosomal dominant neurodevelopmental disorder with language impairments and behavioral abnormalities (OMIM; MIM #618917), a condition characterized by intellectual disability and developmental delay in which seizures are a common feature. The de novo variant identified in our patient maps to the edge of a key ligand binding domain of the AMPA receptor and has not been previously reported in gnomAD or other public databases, making it novel. Our findings provided a long-sought diagnosis for this patient and support the link between GRIA2 and a dominant neurodevelopmental disorder. Cold Spring Harbor Laboratory Press 2022-06 /pmc/articles/PMC9235849/ /pubmed/35534222 http://dx.doi.org/10.1101/mcs.a006172 Text en © 2022 Latsko et al.; Published by Cold Spring Harbor Laboratory Press https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/) , which permits reuse and redistribution, except for commercial purposes, provided that the original author and source are credited. |
spellingShingle | Rapid Communication Latsko, Maeson S. Koboldt, Daniel C. Franklin, Samuel J. Hickey, Scott E. Williamson, Rachel K. Garner, Shannon Ostendorf, Adam P. Lee, Kristy White, Peter Wilson, Richard K. De novo missense variant in GRIA2 in a patient with global developmental delay, autism spectrum disorder, and epileptic encephalopathy |
title | De novo missense variant in GRIA2 in a patient with global developmental delay, autism spectrum disorder, and epileptic encephalopathy |
title_full | De novo missense variant in GRIA2 in a patient with global developmental delay, autism spectrum disorder, and epileptic encephalopathy |
title_fullStr | De novo missense variant in GRIA2 in a patient with global developmental delay, autism spectrum disorder, and epileptic encephalopathy |
title_full_unstemmed | De novo missense variant in GRIA2 in a patient with global developmental delay, autism spectrum disorder, and epileptic encephalopathy |
title_short | De novo missense variant in GRIA2 in a patient with global developmental delay, autism spectrum disorder, and epileptic encephalopathy |
title_sort | de novo missense variant in gria2 in a patient with global developmental delay, autism spectrum disorder, and epileptic encephalopathy |
topic | Rapid Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9235849/ https://www.ncbi.nlm.nih.gov/pubmed/35534222 http://dx.doi.org/10.1101/mcs.a006172 |
work_keys_str_mv | AT latskomaesons denovomissensevariantingria2inapatientwithglobaldevelopmentaldelayautismspectrumdisorderandepilepticencephalopathy AT koboldtdanielc denovomissensevariantingria2inapatientwithglobaldevelopmentaldelayautismspectrumdisorderandepilepticencephalopathy AT franklinsamuelj denovomissensevariantingria2inapatientwithglobaldevelopmentaldelayautismspectrumdisorderandepilepticencephalopathy AT hickeyscotte denovomissensevariantingria2inapatientwithglobaldevelopmentaldelayautismspectrumdisorderandepilepticencephalopathy AT williamsonrachelk denovomissensevariantingria2inapatientwithglobaldevelopmentaldelayautismspectrumdisorderandepilepticencephalopathy AT garnershannon denovomissensevariantingria2inapatientwithglobaldevelopmentaldelayautismspectrumdisorderandepilepticencephalopathy AT ostendorfadamp denovomissensevariantingria2inapatientwithglobaldevelopmentaldelayautismspectrumdisorderandepilepticencephalopathy AT leekristy denovomissensevariantingria2inapatientwithglobaldevelopmentaldelayautismspectrumdisorderandepilepticencephalopathy AT whitepeter denovomissensevariantingria2inapatientwithglobaldevelopmentaldelayautismspectrumdisorderandepilepticencephalopathy AT wilsonrichardk denovomissensevariantingria2inapatientwithglobaldevelopmentaldelayautismspectrumdisorderandepilepticencephalopathy |